Literature DB >> 18180920

Chronic ACE inhibitor treatment increases angiotensin type 1 receptor binding in vivo in the dog kidney.

Tamas G Zober1, Maria Elena Fabucci, Wei Zheng, Phillip R Brown, Esen Seckin, William B Mathews, Kathryn Sandberg, Zsolt Szabo.   

Abstract

PURPOSE: PET imaging has been recently introduced for investigating the type 1 angiotensin II receptor (AT(1)R) in vivo. The goal of the present study was to investigate the effects of acute and chronic exposure to angiotensin converting enzyme inhibitors (ACEI) on the AT(1)R in the dog kidney.
METHODS: Animals were imaged at baseline, after acute intravenous ACEI treatment and after a chronic 2-week exposure to an oral ACEI. Control animals were imaged at identical time points in the absence of ACEI treatment.
RESULTS: In vivo AT(1)R binding expressed by K (i) was increased in the renal cortex by chronic ACEI treatment (p < 0.05). In vitro measurements of AT(1)R density (B (max)) also revealed significant increases in AT(1)R in isolated glomeruli (p < 0.05). Plasma renin activity was increased, but angiotensin II (Ang II) and the Ang II/Ang I ratio showed a weak correlation with chronic ACEI treatment, consistent with an Ang II escape phenomenon.
CONCLUSION: This study reveals, for the first time, that chronic ACEI treatment increases AT(1)R binding in vivo in the dog renal cortex.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18180920     DOI: 10.1007/s00259-007-0667-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  28 in total

1.  In vivo investigation of estrogen regulation of adrenal and renal angiotensin (AT1) receptor expression by PET.

Authors:  Taofeek K Owonikoko; Maria E Fabucci; Philip R Brown; Nighat Nisar; John Hilton; William B Mathews; Hayden T Ravert; Paige Rauseo; Kathryn Sandberg; Robert F Dannals; Zsolt Szabo
Journal:  J Nucl Med       Date:  2004-01       Impact factor: 10.057

2.  Plasma ACE inhibition by five different ACE inhibitors.

Authors:  R Hamlin; F S Pijpers; P J Mandigers
Journal:  Vet Q       Date:  1998       Impact factor: 3.320

Review 3.  What's wrong with Bonferroni adjustments.

Authors:  T V Perneger
Journal:  BMJ       Date:  1998-04-18

4.  Future direction of renal positron emission tomography.

Authors:  Zsolt Szabo; Jinsong Xia; William B Mathews; Phillip R Brown
Journal:  Semin Nucl Med       Date:  2006-01       Impact factor: 4.446

5.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.

Authors:  C S Patlak; R G Blasberg; J D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

6.  Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease.

Authors:  M C Petrie; N Padmanabhan; J E McDonald; C Hillier; J M Connell; J J McMurray
Journal:  J Am Coll Cardiol       Date:  2001-03-15       Impact factor: 24.094

7.  In vivo labeling of angiotensin II receptors with a carbon-11-labeled selective nonpeptide antagonist.

Authors:  S E Kim; U Scheffel; Z Szabo; H D Burns; R E Gibson; H T Ravert; W B Mathews; T G Hamill; R F Dannals
Journal:  J Nucl Med       Date:  1996-02       Impact factor: 10.057

Review 8.  Intrarenal angiotensin II and hypertension.

Authors:  L Gabriel Navar; Hiroyuki Kobori; Minolfa Prieto-Carrasquero
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

9.  Growth hormone regulation of glomerular AT1 angiotensin receptors in adult uninephrectomized male rats.

Authors:  Ka-Yin K Mok; Kathryn Sandberg; Joseph M Sweeny; Wei Zheng; Sunghou Lee; Susan E Mulroney
Journal:  Am J Physiol Renal Physiol       Date:  2003-06-24

10.  Combined angiotensin receptor blocker and ACE inhibitor on myocardial fibrosis and left ventricular stiffness in dogs with heart failure.

Authors:  Kaoru Funabiki; Katsuya Onishi; Kaoru Dohi; Takafumi Koji; Kyoko Imanaka-Yoshida; Masaaki Ito; Hideo Wada; Naoki Isaka; Tsutomu Nobori; Takeshi Nakano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-12       Impact factor: 4.733

View more
  3 in total

Review 1.  Molecular imaging of urogenital diseases.

Authors:  Steve Y Cho; Zsolt Szabo
Journal:  Semin Nucl Med       Date:  2014-03       Impact factor: 4.446

2.  Synthesis and Evaluation of [18F]FEtLos and [18F]AMBF3Los as Novel 18F-Labelled Losartan Derivatives for Molecular Imaging of Angiotensin II Type 1 Receptors.

Authors:  Martha Sahylí Ortega Pijeira; Paulo Sérgio Gonçalves Nunes; Sofia Nascimento Dos Santos; Zhengxing Zhang; Arian Pérez Nario; Efrain Araujo Perini; Walter Miguel Turato; Zalua Rodríguez Riera; Roger Chammas; Philip H Elsinga; Kuo-Shyan Lin; Ivone Carvalho; Emerson Soares Bernardes
Journal:  Molecules       Date:  2020-04-18       Impact factor: 4.411

3.  Modeling of the renal kinetics of the AT1 receptor specific PET radioligand [11C]KR31173.

Authors:  Nedim C M Gulaldi; Jinsong Xia; Tao Feng; Kelvin Hong; William B Mathews; Dawn Ruben; Ihab R Kamel; Benjamin M W Tsui; Zsolt Szabo
Journal:  Biomed Res Int       Date:  2013-09-08       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.